Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
Around 1% of the world’s population lives with epilepsy; yet only 65% of epilepsy patients can manage their symptoms with medication. Currently, surgically removing the lesion in the brain responsible for the condition is the only radical cure for epilepsy. Still, many patients have to take medication for the rest of their life to deal …
Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition. The gene therapy, developed by Stoke Therapeutics, is now in clinical trials. Because most Dravet syndrome cases are caused by a …
University of Virginia School of Medicine researchers have developed a noninvasive way to remove faulty brain circuits that could allow doctors to treat debilitating neurological diseases without the need for conventional brain surgery. The UVA team, together with colleagues at Stanford University, indicate that the approach, if successfully translated to the operating room, could revolutionize …
A next-generation brain implant currently in clinical use for treating refractory epilepsy — to help prevent symptoms including seizures — does not induce changes to patients’ personalities or self-perceptions, a new study of patient experiences shows. The findings, published in the peer-reviewed journal AJOB Neuroscience, will help alleviate some ethical concerns that have been raised around …
In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects. The review, Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks, also found that for most people, the possible long-term risks …
Indiana University School of Medicine researchers are developing a new, noninvasive brain stimulation technique to treat neurological disorders, including pain, traumatic brain injury (TBI), epilepsy, Parkinson’s disease, Alzheimer’s disease and more. “Given the increasing use of brain stimulation in human brain study and treatment of neurological diseases, this research can make a big impact on …
Tohoku University scientists and their colleagues in Germany have revealed that a first-time exposure to only a brief period of brain hyperactivity resulted in an acute breakdown of the inter-cellular network of glial cells. Pharmacological intervention of the glial plasticity may provide a new preventative strategy for fighting epilepsy. The scientists’ findings were detailed in …
In the last five years, the cannabinoid market has experienced enormous growth, mainly due to the legalization and decriminalization of marijuana products across the United States and many other countries around the globe. Nowadays scientists can perform research much easier and it appears that we’re just starting to notice the value of marijuana and its …
For the first time in a groundbreaking clinical trial a team of neurosurgeons.from Sunnybrook Health Sciences Center in Toronto, Ontario, Canada has penetrated the blood brain barrier non-invasively in a human patient named Bonnie Hill who had previously been managing her malignant brain tumor with medication before being given difficult news earlier this year of …
A study conducted by researchers from the Universities of California and Ben-Gurion published in the journal Science Translational Medicine report giving senile mice a synthesized small molecule drug that blocks the TGF beta receptor in astrocytes and traverses the blood brain barrier in mice resulted in the animals having lowered receptor activity, reduced inflammation, as …